some default text...
Select Committee on Science and Technology Second Special Report


LIST OF REPORTS

SCIENCE AND TECHNOLOGY COMMITTEE REPORTS IN THE CURRENT PARLIAMENT

Session 1997-98

First Report: The Implications of the Dearing Report for the Structure and Funding of University Research (HC 303)

Second Report: The Year 2000—Computer Compliance (HC 342)

Third Report: Glaxo Wellcome and SmithKline Beecham: The Merger Proposals (HC 627)

Fourth Report: The Cloning of Animals from Adult Cells (HC 1039)

Fifth Report: British Biotech (HC 888)

Sixth Report: Science and the Comprehensive Spending Review (HC 1040)

First Special Report: The Government's Response to the Committee's Fourth Report, Session 1996-97, The Research Council System: Issues for the Future (HC 302)

Second Special Report: The Government's Response to the Committee's Third Report, Session 1996-97, The Natural Environment Research Council and Research into Climate Change (HC 306)

Third Special Report: The Government's Response to the Committee's First Report, Session 1997-98, The Implications of the Dearing Report for the Structure and Funding of University Research (HC 799)

Fourth Special Report: The Government's Response to the Committee's Fifth Report, Session 1997-98, British Biotech (HC 1185)

Session 1998-99

First Report: The Scientific Advisory System: Genetically Modified Foods (HC 286)

Second Report: The National Endowment for Science, Technology and the Arts (HC 472)

Third Report: The Scientific Advisory System: Mobile Phones and Health (HC 489)

Fourth Report: The Regulation of the Biotechnology Industry (HC 535)

First Special Report: The Government's Response to the Committee's Sixth Report, Session 1997-98, Science and the Comprehensive Spending Review (HC 234)

Second Special Report: The Government's Response to the Committee's Second Report, The National Endowment for Science, Technology and the Arts (HC 822)

Session 1999-2000

First Report: The Year 2000—Computer Compliance: Follow-Up (HC 37)

Second Report: Engineering and Physical Sciences Based Innovation (HC 195-I)

Third Report: Scientific Advisory System: Diabetes and Driving Licences (HC 206-I)

Fourth Report: Glaxo Wellcome and SmithKline Beecham (HC 207-I)

Fifth Report: Government Expenditure on Research and Development: The Forward Look (HC 196-I)

Sixth Report: Cancer Research—A Fresh Look (HC 332-I)

Seventh Report: The Government's Expenditure on Research and Development: The Forward Look—The Government's Reply (HC 723)

First Special Report: Government Response to the Committee's Second Report, Engineering and Physical Sciences Based Innovation (HC 451)

Second Special Report: Joint Working with the Lords Science and Technology Committee

(HC 980)

Third Special Report: Government Response to the Seventh Report of the Science and Technology Committee on the Government's Expenditure on Research and Development: The Forward Look—The Government's Reply (HC 981)

Session 2000-2001

First Report: EQUAL (Extend Quality Life) (HC 43)

Second Report: Corus plc—Research and Development (HC 110)

Third Report: Scientific Advisory System: Scientific Advice on Climate Change (HC 14)

Fourth Report: The Scientific Advisory System (HC 257)

Fifth Report: Genetics and Insurance (HC 174)

Sixth Report: Are We Realising Our Potential? (HC 200-I)

First Special Report: The Work of the Science and Technology Committee 1997-2000

(HC 44)



 
previous page contents

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2001
Prepared 30 April 2001